B7h Triggering Inhibits Umbilical Vascular Endothelial Cell Adhesiveness to Tumor Cell Lines and Polymorphonuclear Cells

Vascular endothelial cells (ECs) are key players in leukocyte recruitment into tissues and metastatic dissemination of tumor cells. ECs express B7h, which is the ligand of the ICOS T cell costimulatory molecule. The aim of this work was to assess the effect of B7h triggering by a soluble form of ICOS (ICOS-Fc) on the adhesion of colon carcinoma cell lines to HUVECs. We found that B7h triggering inhibited HUVEC adhesiveness to HT29 and DLD1 cells (by 50 and 35%, respectively) but not to HCT116 cells. The effect was dependent on the ICOS-Fc dose and was detectable as early as 30 min after treatment and was still present after 24 h. It was inhibited by soluble anti-ICOS reagents (mAb and B7h-Fc) and silencing of B7h on HUVECs, and it was not displayed by an F119S mutated form of ICOS-Fc that does not bind B7h. HUVEC treatment with ICOS-Fc did not modulate expression of adhesion molecules and cytokines, but it substantially downmodulated ERK phosphorylation induced by E-selectin triggering or osteopontin, which may influence HUVEC adhesiveness. Moreover, HUVEC treatment with ICOS-Fc also inhibited adhesion of polymorphonuclear cells and several tumor cell lines from different origins. Therefore, the B7h–ICOS interaction may modulate spreading of cancer metastases and recruitment of polymorphonuclear cells in inflammatory sites, which opens a view on the use of ICOS-Fc as an immunomodulatory drug.

[1]  M. Hickey,et al.  This information is current as Molecules Promotion of Expression of Adhesion Interactions in Human Endothelial Cells via Endothelial − Increases Leukocyte Macrophage Migration Inhibitory Factor , 2010 .

[2]  D. Zhang,et al.  Osteopontin induces angiogenesis through activation of PI3K/AKT and ERK1/2 in endothelial cells , 2009, Oncogene.

[3]  E. Rodríguez,et al.  The altered expression of inflammation-related molecules and secretion of IL-6 and IL-8 by HUVEC from newborns with maternal inactive systemic lupus erythematosus is modified by estrogens , 2008, Lupus.

[4]  M. Gallicchio,et al.  Celecoxib modulates adhesion of HT29 colon cancer cells to vascular endothelial cells by inhibiting ICAM‐1 and VCAM‐1 expression , 2008, British journal of pharmacology.

[5]  M. Cybulsky,et al.  Getting to the site of inflammation: the leukocyte adhesion cascade updated , 2007, Nature Reviews Immunology.

[6]  O. Barreiro,et al.  Functional insights on the polarized redistribution of leukocyte integrins and their ligands during leukocyte migration and immune interactions , 2007, Immunological reviews.

[7]  A. Bradbury,et al.  Construction of miniantibodies for the in vivo study of human autoimmune diseases in animal models , 2007, BMC Biotechnology.

[8]  Haidong Dong,et al.  Costimulation, coinhibition and cancer. , 2007, Current cancer drug targets.

[9]  J. Huot,et al.  Regulation of transendothelial migration of colon cancer cells by E-selectin-mediated activation of p38 and ERK MAP kinases , 2006, Oncogene.

[10]  M. Ferretti,et al.  ICOS cooperates with CD28, IL‐2, and IFN‐γ and modulates activation of human naïve CD4+ T cells , 2006 .

[11]  S. Bakkour,et al.  ICOS-Induced B7h Shedding on B Cells Is Inhibited by TLR7/8 and TLR91 , 2006, The Journal of Immunology.

[12]  E. Jiménez,et al.  P2Y Receptors Activate MAPK/ERK Through a Pathway Involving PI3K/PDK1/PKC-ζ in Human Vein Endothelial Cells , 2006, Cellular Physiology and Biochemistry.

[13]  O. Barreiro,et al.  Endothelial tetraspanin microdomains regulate leukocyte firm adhesion during extravasation. , 2005, Blood.

[14]  R. Nurieva.  Regulation of immune and autoimmune responses by ICOS-B7h interaction. , 2005, Clinical immunology.

[15]  I. Fichtner,et al.  Effect of sialyl Lewis X-glycoliposomes on the inhibition of E-selectin-mediated tumour cell adhesion in vitro. , 2004, Biochimica et biophysica acta.

[16]  S. Blankenberg,et al.  Adhesion molecules and atherosclerosis. , 2003, Atherosclerosis.

[17]  G. Garcı́a-Cardeña,et al.  Lipid Raft Localization of Cell Surface E-Selectin Is Required for Ligation-Induced Activation of Phospholipase Cγ 1 , 2003, The Journal of Immunology.

[18]  G. Lombardi,et al.  Substance P increases neutrophil adhesion to human umbilical vein endothelial cells , 2003, British journal of pharmacology.

[19]  J. Hickman,et al.  Decrease in survival threshold of quiescent colon carcinoma cells in the presence of a small molecule integrin antagonist. , 2003, Molecular pharmacology.

[20]  M. Gräfe,et al.  ICOS-ligand, expressed on human endothelial cells, costimulates Th1 and Th2 cytokine secretion by memory CD4+ T cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[21]  G. Zhu,et al.  Ligand Binding Sites of Inducible Costimulator and High Avidity Mutants with Improved Function , 2002, The Journal of experimental medicine.

[22]  K. Valerie,et al.  Transendothelial Migration of Colon Carcinoma Cells Requires Expression of E-selectin by Endothelial Cells and Activation of Stress-activated Protein Kinase-2 (SAPK2/p38) in the Tumor Cells* , 2001, The Journal of Biological Chemistry.

[23]  S. Rushworth,et al.  HUMAN CD154 INDUCES ACTIVATION OF PORCINE ENDOTHELIAL CELLS AND UP-REGULATION OF MHC CLASS II EXPRESSION , 2001, Transplantation.

[24]  J. Allison,et al.  ICOS co-stimulatory receptor is essential for T-cell activation and function , 2001, Nature.

[25]  G. Freeman,et al.  ICOS is critical for CD40-mediated antibody class switching , 2001, Nature.

[26]  T. Pawson,et al.  ICOS is essential for effective T-helper-cell responses , 2001, Nature.

[27]  M. Gimbrone,et al.  E-Selectin-Dependent Signaling Via the Mitogen-Activated Protein Kinase Pathway in Vascular Endothelial Cells1 , 2000, The Journal of Immunology.

[28]  W. Sha,et al.  B7h, a novel costimulatory homolog of B7.1 and B7.2, is induced by TNFalpha. , 1999, Immunity.

[29]  Rodger P McEver,et al.  Selectin-carbohydrate interactions during inflammation and metastasis , 1997, Glycoconjugate Journal.

[30]  J. Whelan,et al.  An NF kappa B-like factor is essential but not sufficient for cytokine induction of endothelial leukocyte adhesion molecule 1 (ELAM-1) gene transcription. , 1991, Nucleic Acids Research.

[31]  R. Cotran,et al.  Identification of an inducible endothelial-leukocyte adhesion molecule. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[32]  D. Dexter,et al.  N,N-dimethylformamide-induced alteration of cell culture characteristics and loss of tumorigenicity in cultured human colon carcinoma cells. , 1979, Cancer research.

[33]  J. Huot,et al.  Selectins and selectin ligands in extravasation of cancer cells and organ selectivity of metastasis , 2007, Clinical & Experimental Metastasis.

[34]  M. Ferretti,et al.  ICOS cooperates with CD28, IL-2, and IFN-gamma and modulates activation of human naïve CD4+ T cells. , 2006, European journal of immunology.

[35]  J. Huot,et al.  Adhesion of HT-29 colon carcinoma cells to endothelial cells requires sequential events involving E-selectin and integrin β4 , 2004, Clinical & Experimental Metastasis.

[36]  Andreas Hutloff,et al.  ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28 , 1999, Nature.